| Phase 118 trials |
|
Phase 1
|
NCT01269411 |
Jul 2011 → Feb 2012 |
adult brainstem glioma, adult glioblastoma, anaplastic oligodendroglioma, giant cell glioblastoma +1 |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT01238133 |
Dec 2010 → Jan 2014 |
female breast carcinoma, triple-negative breast carcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT01208441 |
Nov 2010 → Dec 2011 |
Her2-receptor negative breast cancer, estrogen-receptor positive breast cancer, female breast carcinoma, progesterone-receptor positive breast cancer |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT01236586 |
Oct 2010 → Apr 2011 |
Wilms tumor, brain neoplasm, lymphoma, osteosarcoma |
National Cancer Institute (NCI) |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT01149356 |
Oct 2010 → Dec 2012 |
Her2-receptor negative breast cancer, estrogen-receptor positive breast cancer, female breast carcinoma, male breast carcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT01218620 |
Sep 2010 → Jul 2012 |
neoplasm |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01198535 |
Sep 2010 → Jul 2012 |
colon mucinous adenocarcinoma, colon signet ring cell adenocarcinoma, rectal signet ring cell adenocarcinoma, rectum mucinous adenocarcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT01193881 |
Aug 2010 → Aug 2015 |
non-small cell lung carcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT01192763 |
Aug 2010 → Jan 2012 |
pancreatic adenocarcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT01198184 |
Aug 2010 → Jul 2013 |
cancer of unknown primary site, endometrial carcinoma, endometrial serous adenocarcinoma, renal cell carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01158274 |
Jun 2010 → Aug 2012 |
AIDS-related primary central nervous system lymphoma, Burkitt lymphoma, Her2-receptor negative breast cancer, Hodgkins lymphoma +25 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01145456 |
Jun 2010 → Nov 2013 |
pancreatic adenocarcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01119599 |
May 2010 → Jun 2013 |
acoustic neuroma, adult brain ependymoma, adult brainstem glioma, adult choroid plexus neoplasm +23 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01131234 |
May 2010 → Sep 2014 |
adult anaplastic ependymoma, adult brainstem glioma, adult glioblastoma, anaplastic astrocytoma +15 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01088763 |
Mar 2010 → May 2011 |
Burkitt lymphoma, Hodgkins lymphoma, T-cell childhood acute lymphocytic leukemia, T-cell large granular lymphocyte leukemia +33 |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT01096355 |
Feb 2010 → Jul 2012 |
cancer of unknown primary site |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01071564 |
Nov 2009 → Jun 2014 |
triple-negative breast carcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT00532090 |
Nov 2007 → Aug 2010 |
neoplasm |
Hoffmann-La Roche |
Completed
|
No outcome recorded
|
|
| Phase 1/24 trials |
|
Phase 1/2
|
NCT01189240 |
Dec 2010 → Jan 2013 |
adult glioblastoma, anaplastic astrocytoma, anaplastic oligodendroglioma, giant cell glioblastoma +1 |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT01217411 |
Oct 2010 → Nov 2011 |
HER2 positive breast carcinoma, Her2-receptor negative breast cancer, cutaneous melanoma, male breast carcinoma +3 |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT01196416 |
Aug 2010 → Aug 2015 |
cutaneous melanoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT01154452 |
Jun 2010 → Feb 2015 |
Ewing sarcoma/peripheral primitive neuroectodermal tumor, Kaposi's sarcoma, adult epithelioid sarcoma, adult extraskeletal osteosarcoma +18 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
| Phase 213 trials |
|
Phase 2
|
NCT01251172 |
Dec 2010 → Jul 2012 |
plasma cell myeloma |
National Cancer Institute (NCI) |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT01270438 |
Dec 2010 → Aug 2011 |
colon adenocarcinoma, rectum adenocarcinoma |
National Cancer Institute (NCI) |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT01122901 |
Dec 2010 → Aug 2015 |
adult glioblastoma, giant cell glioblastoma, gliosarcoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT01232829 |
Oct 2010 → Jul 2012 |
pancreatic adenocarcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01120275 |
Oct 2010 → May 2013 |
acral lentiginous melanoma, lentigo maligna melanoma, nodular malignant melanoma, superficial spreading melanoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT01216787 |
Sep 2010 → Nov 2011 |
melanoma |
National Cancer Institute (NCI) |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT01193868 |
Sep 2010 → Apr 2014 |
non-small cell lung carcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT01200810 |
Aug 2010 → Aug 2012 |
prostate adenocarcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT01175343 |
Jul 2010 → Oct 2012 |
fallopian tube carcinoma, ovarian carcinoma, primary peritoneal carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01151449 |
Jun 2010 → Jul 2012 |
male breast carcinoma, triple-negative breast carcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT01141569 |
Jun 2010 → May 2012 |
clear cell renal carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01116687 |
May 2010 → May 2011 |
rectal cancer |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01070927 |
Jan → Aug 2010 |
non-small cell lung carcinoma |
Hoffmann-La Roche |
Completed
|
No outcome recorded
|
|